Skip to main content

Medications for Breast Cancer

The medications listed below are related to or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
abemaciclib 7.8 40 reviews for abemaciclib to treat Breast Cancer Rx N
Generic name:
abemaciclib systemic
Brand name:
Verzenio
Drug class:
CDK 4/6 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Abraxane 9.7 3 reviews for Abraxane to treat Breast Cancer Rx D N
Generic name:
paclitaxel protein-bound systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
ado-trastuzumab emtansine Rate Add review Rx D N
Generic name:
ado-trastuzumab emtansine systemic
Brand name:
Kadcyla
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Afinitor 4.3 11 reviews for Afinitor to treat Breast Cancer Rx D N
Generic name:
everolimus systemic
Drug class:
mTOR inhibitors, selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
alpelisib 7.4 5 reviews for alpelisib to treat Breast Cancer Rx N
Generic name:
alpelisib systemic
Brand name:
Piqray
Drug class:
PI3K inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
anastrozole 5.2 216 reviews for anastrozole to treat Breast Cancer Rx D N
Generic name:
anastrozole systemic
Brand name:
Arimidex
Drug class:
hormones/antineoplastics, aromatase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Arimidex 5.7 73 reviews for Arimidex to treat Breast Cancer Rx D N
Generic name:
anastrozole systemic
Drug class:
hormones/antineoplastics, aromatase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Aromasin 4.9 24 reviews for Aromasin to treat Breast Cancer Rx D N
Generic name:
exemestane systemic
Drug class:
hormones/antineoplastics, aromatase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
atezolizumab Off-label 5.5 2 reviews for atezolizumab to treat Breast Cancer Rx N
Generic name:
atezolizumab systemic
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Off-label:
Yes
bevacizumab Off-label Rate Add review Rx C N
Generic name:
bevacizumab systemic
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Off-label:
Yes
capecitabine 6.5 10 reviews for capecitabine to treat Breast Cancer Rx D N
Generic name:
capecitabine systemic
Brand name:
Xeloda
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
capivasertib Rate Add review Rx N
Generic name:
capivasertib systemic
Brand name:
Truqap
Drug class:
multikinase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
cyclophosphamide Rate Add review Rx D N
Generic name:
cyclophosphamide systemic
Brand name:
Frindovyx
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
datopotamab deruxtecan Rate Add review Rx N
Generic name:
datopotamab deruxtecan systemic
Brand name:
Datroway
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Datroway Rate Add review Rx N
Generic name:
datopotamab deruxtecan systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
docetaxel 3.9 8 reviews for docetaxel to treat Breast Cancer Rx D N
Generic name:
docetaxel systemic
Brand name:
Taxotere
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
doxorubicin 5.0 4 reviews for doxorubicin to treat Breast Cancer Rx D N
Generic name:
doxorubicin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
elacestrant Rate Add review Rx N
Generic name:
elacestrant systemic
Brand name:
Orserdu
Drug class:
hormones/antineoplastics, estrogen receptor antagonists
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Enhertu 8.5 4 reviews for Enhertu to treat Breast Cancer Rx N
Generic name:
fam-trastuzumab deruxtecan systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
eribulin 2.0 1 review for eribulin to treat Breast Cancer Rx D N
Generic name:
eribulin systemic
Brand name:
Halaven
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
esterified estrogens Rate Add review Rx X N
Generic name:
esterified estrogens systemic
Brand name:
Menest
Drug class:
estrogens
For consumers:
dosage, interactions, side effects
everolimus 4.3 13 reviews for everolimus to treat Breast Cancer Rx D N
Generic name:
everolimus systemic
Brand name:
Afinitor
Drug class:
mTOR inhibitors, selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
exemestane 5.1 118 reviews for exemestane to treat Breast Cancer Rx D N
Generic name:
exemestane systemic
Brand name:
Aromasin
Drug class:
hormones/antineoplastics, aromatase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
fam-trastuzumab deruxtecan 8.5 4 reviews for fam-trastuzumab deruxtecan to treat Breast Cancer Rx N
Generic name:
fam-trastuzumab deruxtecan systemic
Brand name:
Enhertu
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Faslodex 4.5 2 reviews for Faslodex to treat Breast Cancer Rx D N
Generic name:
fulvestrant systemic
Drug class:
hormones/antineoplastics, estrogen receptor antagonists
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Learn more about Breast Cancer

Care guides

Symptoms and treatments

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.